tm logo

Monitor this mark

View On USPTO

KYGIVI
Live/Pending
THIRD EXTENSION - GRANTED

granted

on 03 Oct 2024

Last Applicant/ Owned by

UCB BIOSCIENCES, INC.

4000 PARAMOUNT PARKWAY, SUITE 200

MORRISVILLE

NC

27560

Serial Number

97070389 filed on 12th Oct 2021

Registration Number

N/A

Correspondent Address

Kumiko Ide

Kumiko Ide Wenderoth, Lind & Ponack, L.L.P.

Washington, DC 20036

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

KYGIVI

Pharmaceutical preparations for the treatment of tk2 diseases and disorders, mitochondrial depletion syndrome disease and disorders, and enzyme deficiency diseases and disorders

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of tk2 diseases and disorders, mitochondrial depletion syndrome disease and disorders, and enzyme deficiency diseases and disorders

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97070389

Mark Type

No Service/Collective Mark

Attorney Docket Number

No TM24-0126

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
04th Oct 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04th Oct 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
04th Oct 2024SOU EXTENSION 3 GRANTED
22nd Jul 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11th Jul 2024SOU TEAS EXTENSION RECEIVED
11th Jul 2024SOU EXTENSION 3 FILED
11th Mar 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
11th Mar 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11th Mar 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06th Mar 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED